Stock Analiz

GILD vs MRNA stock comparison

Gilead Sciences vs. Moderna · data as of November 13, 2026

Gilead Sciences (GILD) has a market value of about $208.5B, Moderna (MRNA) about $90.4B. Over their latest twelve months Gilead Sciences had revenue of $31.0B and Moderna $2.5B.

On our five checks Gilead Sciences scores higher: 2.8 out of 5 (average) against 1.0 (weak).

By area, the stronger company is Gilead Sciences on value; Gilead Sciences on future growth; Gilead Sciences on track record; Gilead Sciences on financial health; Gilead Sciences on shareholder returns.

Gilead Sciences leads on 15 of the compared lines and Moderna on 3.

Side by side

GILDMRNA
Size and price
Market cap$208.5B$90.4B
Share price$168.08$223.37
Score
Overall score (of 5)2.81.0
Value10
Future growth21
Track record41
Financial health32
Shareholder returns41
Valuation
P/E (TTM)——
Forward P/E20.3—
Price / free cash flow15.1—
Price / sales6.735.8
EV / EBITDA559.5—
PEG——
DCF value vs. price−35%—
Business
Revenue$31.0B$2.5B
Net income-$3.9B-$2.8B
Free cash flow$13.8B-$2.0B
Net margin-12.5%-110.5%
Gross margin (5-yr avg.)77.6%59.9%
ROIC (5-yr avg.)12.2%9.4%
Growth
Revenue growth (1 yr)2.4%-39.9%
Revenue growth (5 yrs, per year)3.6%19.3%
EPS growth (5 yrs, per year)132.4%—
Balance sheet and payouts
Net cash (cash minus debt)-$19.8B$3.9B
Dividend yield1.95%None
Shareholder yield2.9%0.0%
Analysts
Upside to average target+4%−29%
Consensus ratingBuyHold

Highlighted = the better figure on that line. Revenue, net income and free cash flow: GILD TTM to September 30, 2026, MRNA TTM to September 30, 2026. Not investment advice.

Frequently asked questions

Which is the better stock, Gilead Sciences or Moderna?

We do not give buy or sell advice. On our five checks (value, growth, track record, financial health and shareholder returns) Gilead Sciences scores 2.8 out of 5 and Moderna 1.0; the table shows where each one is stronger.

Which grows faster, Gilead Sciences or Moderna?

Over five years Moderna grew revenue about 19.3% a year and Gilead Sciences about 3.6% a year.

Which pays a higher dividend?

Gilead Sciences yields 1.95% and Moderna nothing (no dividend).

Full Gilead Sciences analysis → Full Moderna analysis →

More comparisons

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.